These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


655 related items for PubMed ID: 20609687

  • 1. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
    Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S.
    Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
    [Abstract] [Full Text] [Related]

  • 2. The obesity paradox: body mass index and outcomes in patients with heart failure.
    Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM.
    Arch Intern Med; 2005 Jan 10; 165(1):55-61. PubMed ID: 15642875
    [Abstract] [Full Text] [Related]

  • 3. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ.
    Am J Med; 2007 Oct 10; 120(10):863-70. PubMed ID: 17904457
    [Abstract] [Full Text] [Related]

  • 4. Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
    Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH.
    Circulation; 2005 Nov 22; 112(21):3247-55. PubMed ID: 16286585
    [Abstract] [Full Text] [Related]

  • 5. Impact of lipid-lowering therapy on outcomes in atrial fibrillation.
    Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S.
    Am J Cardiol; 2010 Jun 15; 105(12):1768-72. PubMed ID: 20538128
    [Abstract] [Full Text] [Related]

  • 6. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
    Genovesi S, Vincenti A, Rossi E, Pogliani D, Acquistapace I, Stella A, Valsecchi MG.
    Am J Kidney Dis; 2008 Feb 15; 51(2):255-62. PubMed ID: 18215703
    [Abstract] [Full Text] [Related]

  • 7. Relation of body mass index to outcome in patients with known or suspected coronary artery disease.
    Galal W, van Domburg RT, Feringa HH, Schouten O, Elhendy A, Bax JJ, Awara AM, Klein J, Poldermans D.
    Am J Cardiol; 2007 Jun 01; 99(11):1485-90. PubMed ID: 17531566
    [Abstract] [Full Text] [Related]

  • 8. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB.
    Am J Med; 2013 Jul 01; 126(7):640.e9-17. PubMed ID: 23601271
    [Abstract] [Full Text] [Related]

  • 9. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D.
    Nephrol Dial Transplant; 2009 Sep 01; 24(9):2871-6. PubMed ID: 19369686
    [Abstract] [Full Text] [Related]

  • 10. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.
    Frost L, Hune LJ, Vestergaard P.
    Am J Med; 2005 May 01; 118(5):489-95. PubMed ID: 15866251
    [Abstract] [Full Text] [Related]

  • 11. Relation of obesity to recurrence rate and burden of atrial fibrillation.
    Guglin M, Maradia K, Chen R, Curtis AB.
    Am J Cardiol; 2011 Feb 15; 107(4):579-82. PubMed ID: 21195377
    [Abstract] [Full Text] [Related]

  • 12. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Feb 15; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 13. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO.
    Am J Med; 2009 Dec 15; 122(12):1106-14. PubMed ID: 19682667
    [Abstract] [Full Text] [Related]

  • 14. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW, Tonev ST, Spinler SA, Levine GN, Gallo R, Ducas J, Goodman SG, Antman EM, Becker RC, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM, SYNERGY Trial Investigators.
    Int J Cardiol; 2010 Mar 04; 139(2):123-33. PubMed ID: 19012977
    [Abstract] [Full Text] [Related]

  • 15. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death.
    Nigam A, Wright RS, Allison TG, Williams BA, Kopecky SL, Reeder GS, Murphy JG, Jaffe AS.
    Int J Cardiol; 2006 Jun 16; 110(2):153-9. PubMed ID: 16043245
    [Abstract] [Full Text] [Related]

  • 16. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.
    Badheka AO, Rathod A, Kizilbash MA, Bhardwaj A, Ali O, Afonso L, Jacob S.
    Am J Cardiol; 2011 Nov 01; 108(9):1283-8. PubMed ID: 21855829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Impact of overweight on clinical outcomes in patients undergoing coronary revascularization].
    Kang JP, Ma CS, Lü Q, Nie SP, Liu XM, Liu XH, DU X, Hu R, Dong JZ, Chen F, Lü SZ, Gu CX, Huang FJ, Wu XS.
    Zhonghua Yi Xue Za Zhi; 2010 May 25; 90(20):1381-4. PubMed ID: 20646625
    [Abstract] [Full Text] [Related]

  • 19. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery.
    Mullen JT, Moorman DW, Davenport DL.
    Ann Surg; 2009 Jul 25; 250(1):166-72. PubMed ID: 19561456
    [Abstract] [Full Text] [Related]

  • 20. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 25; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.